Skip to main content
padlock icon - secure page this page is secure

Cyclosporin A in the treatment of refractory immune thrombocytopenia purpura in children

Buy Article:

$52.00 + tax (Refund Policy)

Abstract: Patients with refractory autoimmune thrombocytopenia do not respond to standard therapy with high-dose corticosteroids, intravenous immunoglobulin, and splenectomy. We describe the cases of two patients with refractory autoimmune thrombocytopenia treated with oral cyclosporin A (CsA) to evaluate the efficacy of this alternative therapy. Blood pressure and hepatic and renal function were in the normal range before initiation of treatment. Induction therapy with pulses of high-dose methylprednisolone was used for 3 consecutive days to improve the initial immune suppression. Gradual dose reduction of CsA, according the platelet count, minimized the long-term adverse effects of CsA. Oral CsA with pulses of high-dose methylprednisolone induced remission of the thrombocytopenia. Gradual weaning of CsA over months, according the platelet count, produced no observable adverse effects of the CsA. Rapid dose reduction caused thrombocytopenia, which resolved with higher dosages of CsA. Our cases show the efficacy of CsA for refractory immune thrombocytopenia. This therapeutic option with oral CsA as an additional salvage option may avoid splenectomy and the adverse effects of long-term corticosteroids. Larger clinical investigations are necessary to establish the indications and therapeutic regimen for CsA in immune thrombocytopenia.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: immune suppression for ITP; immune thrombocytopenia purpura (ITP); splenectomy-sparing treatment for ITP

Document Type: Research Article

Affiliations: 1: Department of Pediatrics, Hadassah Hospital, Ein Kerem, Jerusalem, Israel, and 2: Clinical Pharmacology/Toxicology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Canada 3: Division of Hematology and Oncology and

Publication date: May 1, 2001

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more